ONCOTARGET’S WORLDCLASS JOURNAL

Medical or scientific information in the internet can be found in various ways. One of these ways is through published journals. These journals may be quite hard to find, considering the wide range of scientific information concerning medical studies that is found in the internet. Oncotarget makes it easy for the public to access scientific and medical journals concerning oncology- the scientific study of diagnosis, prevention and treatment of cancer. In addition to offering a broad range of information, Oncotarget is an open journal where the public is able to access scientific or medical information sfreely. This journal, with its chief editors Mikhail Blagosklonny and Andrei V. Gudkov, has proved to be a key role player when it comes to the publication of scientific research papers.

Oncotarget is described as a peer-reviewed journal with an international popularity. When we talk about cancer, the journal covers all angles of Oncology from the potential targets for therapy and treatment procedures employed for improvement of the cancer patients’ management to the pathological grounds of all cancers. To expound on therapy, as part of the entire patient care process, punitive care is included for the patients. The journal also tends to involve information about how management programs and new therapeutic agents and procedures affect the patients’ perspectives such as satisfaction, quality of life and adherence. The journal takes an extra step of analyzing the evidence behind new and existing therapies. Oncotarget then defines the usage of these therapies in relation to the uptake and acceptance by the patient and health care professional.

Oncotarget works together with top rated profile scientific archives and indexes to provide quality and authentic information to the public. It has now accelerated the indexing processes by publishing two issues in a week. After the pages and issue numbers are assigned, they appear permanently on PubMed. The journal shows diversity by involving publications of subsections that relate to oncology. These include Pathology, Immunology, Microbiology, Autophathy and Chromosomes just to name but a few. According to a calculation using research gate based on average citation counts from work published in this journal, Oncotarget’s journal impact is at 3.41.


OSI Industries: Purchased a Former Tyson Food Distribution Plant

The OSI Group is an organization that provides a variety of services to the food as well as the retail industries. At present, OSI Group is based out of Illinois. The organization has been in business since the early 1900’s. In addition, OSI Group was said to be worth over $3 Billion dollars in early 2013.

Sheldon Lavin is currently the CEO of the OSI Group. Mr. Lavin has a great deal of responsibility on a daily basis. Lavin is continually researching the food industry trying to come up with new and innovative methods of servicing a very demanding and growing fast food industry.

OSI purchased a former Tyson Food distribution plant in 2016 within the South side of Chicago. OSI purchased the plant for a little over 7 million dollars. The deal was finalized in November 2016.

The OSI Group first started as Otto & Sons and it served a very localized area. However, by the early 1950’s the company had experienced substantial growth. By the 1960’s The OSI Group was a regular supplier of food products to major restaurant chains such as Mc Donalds. To date, Mc Donalds is still one of OSI’s major clients. OSI supplies Mc Donalds and other food chains with beef and other meat products used on a regular basis.

OSI Group was one of the first organizations to implement the use of Cryogenic Food Processing as means of preserving food products for prolonged periods of time. Once the company expanded into the Chicago area in the 1970’s, every one of OSI Group’s processing plants used the Cryogenic Food Processing Method. By the mid 1970’s the OSI Group became known nationally as a major distributor of food products to fast food and restaurant chains. The company is listed as one of America’s 100 top food company’s.

In the early 1990’s OSI Group opened processing plants in China and Germany. OSI’s expansion efforts were quite successful and the company has a strong and profitable client base. Sheldon Lavin efforts have proved successful and he has become a highly respected and well known businessman.

Forbes has published several articles about the OSI Group and their success. In addition, Forbes stated that in 2016, OSI was one of the largest private organizations earning substantial revenue which well exceeded 5 Billion dollars. The most recent plants opened by OSI Group are located in Geneva, Iowa and Riverside California.

OSI Group info: www.foodworks.pl/en/osi-group-en.html


Kerrisdale Short-stocks a Public Company

Kerrisdale Capital Management’s CEO and founder, Sahm Adrangi has gathered in the recent past one hundred million dollars from investors. The fund is planning to short stock an upcoming public company. This information was given to the Reuters by a person who has the insight into the plan. The person did not want his identity known to the public as the matter was not to be released to the public.

Being a relatively small company, the big sum of money the co-investors raised was one of a kind that the company has ever raised in a single event since its launching. It is common for a large sum of money to be raised by hedge fund managers especially when it comes to helping a power plant facing challenges or even crisis in mortgage security. Kerrisdale plans to use the money in betting against an unnamed public company that is intended to be launched in the mid of May.

The success in gathering the amount is a clear indication of the firm’s success in winning the trust of the community according to an email that Adrangi wrote to the investors. Adrangi went on to say that they have succeeded in taking the $10 worth company. Adrangi together with his colleague, Shane Wilson is now planning on items to us in convincing the public of their intentions. Kerrisdale has already started sinking roots into the company as they have already begun buying stock.

Sahm Adrangi launched the Kerrisdale Capital Management in the year 2009 with a capital less than 1 million dollars. He has involved himself actively as the Chief Investment Officer to ensure that the company grows. The firm is currently managing about five hundred million dollars with the new amount collected.

Sahm Adrangi graduated with Bachelor of Arts in economics and started his career at Deutsche Bank in finance. He was responsible for credit in which he performed excellently to leverage loan debt financing. In addition to this, he was also an advisor to the creditor committee at the Chanin Capital Partners. Afterwards, he was involved in the multi-billion-dollar distressed debt hedge fund.

For details: www.kerrisdalecap.com/


Jason Hope believes that life expectancy is nowhere near its ceiling

Over the last few decades, there has been much speculation among scientists as to what the ceiling for human life expectancy is. Cases like that of Jeanne calmest, live to the age of 122 years old, strongly suggest that current life expectancies are nowhere near the maximum ceiling. In fact, many scientists have suggested that life expectancy of humans has far greater potential than has been achieved thus far. With optimal care and, perhaps, through such novel technologies as genetic engineering, many biologists believe that the human life ceiling can be extended to 125 years and beyond.

Jason Hope is one of America’s most accomplished internet entrepreneurs. Across a career spanning decades, he has founded some of the most innovative companies in the history of technology. These include such stunning as successes as Jawa, the first premium mobile content streaming service, which was able to beat Apple and the iTunes store to their own business model by more than 10 years.

Hope has long held an intense interest in medicine, particularly in the ability of science to stave off the effects of aging, potentially leading to a dramatic increase in human life expectancy. Recently, Hope recently announced that he had donated more than $500,000 to the SENS Foundation, one of the most prestigious private medical research organizations in the United States today. Hope has stated that the majority of this money will go to atherosclerosis research, a disease responsible for the vast majority of deaths in the United States.

Atherosclerosis is directly responsible for the majority of cases of coronary artery disease and heart attack in the United States. But it is also responsible for diseases ranging from kidney failure to peripheral artery disease as well as stroke and cerebral hemorrhages. Hope has even more profound reasons for funding atherosclerosis than merely the elimination of these diseases. Hope believes that if modern science is able to understand the processes that lead to atherosclerosis formation at the molecular level, that knowledge may be successfully transferred to other fields, enabling physicians to wield new tools in the fight against many of the diseases associated with advancing age.

As an avid reader of the medical literature, Hope has long been aware that the same molecular processes associated with the formation of atherosclerosis are strongly associated with other disease processes, such as arthritis, glaucoma and even the wrinkling of skin. It is this insight that has led him to believe that it may be possible to eliminate all of these diseases.

Jason Hop’s Social Media: www.facebook.com/jason.r.hope